Syphilis is an infection that can be difficult to recognize from symptoms alone. Some people may have noticeable signs, while others may have few or no obvious symptoms. Signs can also change over time. This is one reason laboratory testing is an important part of the diagnosis.
But syphilis testing teaches an important lesson about laboratory medicine: one test does not always answer every question.
Laboratories use different tests because the tests look for different kinds of evidence. One type can provide useful information about whether there may be an infection, while another can provide evidence that the person’s immune system has responded specifically to the organism that causes syphilis. The results then have to be considered together with the person’s history and clinical assessment.
What is syphilis?
Syphilis is an infection caused by a bacterium called Treponema pallidum. It can progress through different stages, and the signs can vary from one stage to another. Because symptoms may be mild, temporary or absent, laboratory testing can be important even when the illness is not obvious.
Testing is therefore not simply about asking whether someone has a symptom. It is about looking for laboratory evidence that can support or help rule in an infection in the appropriate clinical setting.
Why are two broad kinds of blood tests used?
The most commonly used blood tests for syphilis fall into two broad groups: treponemal tests and non-treponemal tests.
These names may sound complicated, but the basic idea is straightforward.
Treponemal tests look for antibodies directed against the bacterium that causes syphilis. Examples include TPPA and other laboratory methods that detect antibodies specifically associated with T. pallidum.
Non-treponemal tests, such as RPR and VDRL, look for antibodies produced in response to substances associated with the infection and tissue changes. These tests are useful for screening in many settings and are also useful when monitoring changes after treatment.
Because the two groups provide different kinds of evidence, they work best as part of a testing algorithm rather than being treated as interchangeable tests.
Why can’t the laboratory simply use one test?
Every laboratory test has strengths and limitations.
A non-treponemal test can sometimes be reactive for reasons other than syphilis. Other infections, pregnancy and some other medical conditions can produce a reactive result. A reactive result therefore needs appropriate follow-up rather than being treated as proof of syphilis by itself.
A treponemal test has a different limitation. Once a person has developed antibodies to syphilis, those antibodies often remain detectable for a very long time, even after successful treatment. A positive treponemal test therefore cannot, by itself, tell the laboratory whether an infection is current or was treated in the past.
Using both types of information helps the healthcare team make better sense of the result.
The traditional testing approach
In a traditional testing algorithm, the laboratory starts with a non-treponemal test such as RPR or VDRL.
If that first test is reactive, a treponemal test is then used to provide additional evidence that the result is related to syphilis.
This approach has been used for many years and remains an accepted testing strategy.
The important point for the public is not to memorize the sequence. It is to understand why the laboratory does not stop at one reactive result.
The reverse testing approach
Some laboratories use the reverse sequence approach.
Here, an automated treponemal test is used first. If it is reactive, the laboratory then performs a quantitative non-treponemal test such as RPR to add another type of evidence.
If the two results do not agree, the laboratory may perform another treponemal test using a different method to help resolve the difference. CDC’s 2024 laboratory recommendations recognize both the traditional and reverse testing algorithms as acceptable approaches.
This explains why two people may have apparently different test sequences at different laboratories without one laboratory necessarily doing something incorrectly. The testing algorithm can depend on the laboratory’s equipment, workload, resources and patient population.
What if the tests disagree?
Disagreement between tests does not mean that the laboratory has failed.
It means the available evidence needs another look.
For example, a person may have a reactive treponemal screening test followed by a non-reactive non-treponemal test. In this situation, a second treponemal test using a different method may be used to help determine whether the initial result is consistent with syphilis.
The meaning of such a pattern depends on important information such as previous syphilis treatment, the possibility of a recent infection and the clinical assessment. CDC specifically recommends that laboratories use both treponemal and non-treponemal methods within an appropriate algorithm rather than relying on one reactive result alone.
Why previous treatment matters
Previous treatment is one of the most important pieces of information when syphilis results are being interpreted.
A treponemal test may remain positive long after treatment. Therefore, finding treponemal antibodies does not automatically mean that a person has a new or untreated infection.
Non-treponemal tests are different. Their measured levels, often reported as titres, can change over time and can be used to help monitor response to treatment.
For follow-up testing, CDC recommends using the same type of non-treponemal test when comparing results. RPR and VDRL results should not simply be treated as interchangeable numbers because they are different methods.
This is a good example of why laboratory results should not be interpreted by comparing isolated numbers without knowing how the tests were performed.
Can syphilis testing be negative early in infection?
Yes. Laboratory tests do not become positive immediately after infection.
The body’s antibody response develops over time, so very early infection can sometimes produce negative blood-test results. CDC notes that development of antibodies detectable by both major groups of syphilis tests can take time after infection.
This means that a negative result cannot always be separated from the timing of the test. When there is a strong clinical concern or a recent possible exposure, a healthcare professional may decide that additional assessment or repeat testing is appropriate.
What about rapid syphilis tests?
Not all syphilis testing has to take place in a large laboratory.
WHO’s 2024 recommendations include dual rapid tests that can provide both treponemal and non-treponemal information as an additional option within syphilis testing strategies. These approaches can be useful where access to laboratory services is limited or where rapid results are particularly valuable.
A rapid result, however, is still a laboratory or diagnostic result that needs to be interpreted according to the type of test used. Rapid does not mean that every question about an infection has been answered.
Why laboratory quality matters
Using the correct testing algorithm is only part of reliable syphilis testing.
The laboratory also needs appropriate specimens, trained staff, validated methods, quality control and systems that help ensure results are accurate and reported correctly.
WHO’s syphilis serology proficiency programme exists specifically to assess laboratory performance and help verify the accuracy and reliability of syphilis testing.
This matters because a laboratory result can influence important decisions about a person’s health. Reliable testing therefore depends not only on the test kit itself, but also on the processes surrounding it.
Why a laboratory result is not the whole diagnosis
Syphilis diagnosis can involve more than a blood test.
Healthcare professionals may consider symptoms, physical findings, sexual and medical history, previous treatment and laboratory results together. In some situations, examination of material from a lesion or other specialized testing may also be considered.
WHO describes syphilis diagnosis as a process that can involve clinical history, physical examination and laboratory testing.
This is why the same laboratory result can have different implications depending on the circumstances in which it was obtained.
What the laboratory can and cannot tell you
A syphilis laboratory report can provide important evidence, but it does not necessarily answer every question on its own.
Testing can help establish whether laboratory evidence of syphilis is present. It can also provide information that helps distinguish different testing patterns and, with appropriate non-treponemal testing, can help clinicians monitor changes over time.
But a laboratory report by itself may not tell you exactly when an infection began, whether a positive treponemal result represents a current untreated infection or an infection treated in the past, or what treatment an individual person needs.
Those questions require the laboratory result to be interpreted alongside the person’s clinical and treatment history.
The laboratory perspective
Syphilis testing is a useful example of why laboratory medicine is more than producing a positive or negative result.
The laboratory chooses methods that provide complementary information. It follows a defined testing algorithm. It checks the quality of the testing process. It links related results so that the healthcare professional receives the complete picture.
From the public’s perspective, the most important lesson is simple: if more than one syphilis test appears on a laboratory report, that does not necessarily mean that the laboratory is repeating the same test. Different tests can be looking for different evidence, and that evidence becomes more useful when considered together.
What to remember
Syphilis can occur without obvious symptoms, so laboratory testing can play an important role in diagnosis.
There are two broad groups of blood tests: treponemal tests, which look for antibodies directed against the bacterium that causes syphilis, and non-treponemal tests, such as RPR and VDRL, which provide a different kind of evidence.
Neither group should simply be treated as a complete answer on its own. CDC recommends using the two types of tests in an appropriate testing algorithm.
A treponemal test can remain positive after treatment, while non-treponemal test results can be useful for monitoring changes over time. The same non-treponemal testing method should be used when comparing results.
Very early infection may not yet be detectable by blood testing, so timing and clinical circumstances matter.
The key lesson is simple: syphilis testing is not about one number. It is about putting different pieces of laboratory evidence together with the person’s history and clinical assessment.
Educational note: This article is for public health education and laboratory literacy. It does not provide a personal diagnosis or treatment recommendation. Anyone concerned about possible syphilis or another sexually transmitted infection should discuss testing and results with a qualified healthcare professional or appropriate testing service.